AIIMS study proves Covaxin’s effectiveness: Bharat Biotech | Hyderabad News – Times of India

HYDERABAD: A day after a study conducted by AIIMS on healthcare professionals, showing Covaxin has a 50% efficacy against symptomatic Covid-19, were published in the Lancet Infectious Diseases journal, Bharat … Read More

covaxin: Lancet Infectious Diseases study compare well with phase 3 clinical trials of Covaxin: Bharat Biotech | India News – Times of India

NEW DELHI: Commenting on the study of the Lancet Infectious Diseases on the effectiveness of Covaxin (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare … Read More

Covaxin Latest News: 50% Covaxin efficacy may not be as bad as it seems | Delhi News – Times of India

NEW DELHI: A study conducted by AIIMS has shown that two doses of Covaxin, the indigenous vaccine developed by Indian Council of Medical Research in collaboration with Bharat Biotech, is … Read More

2.45 lakh people skip second dose of Covid-19 vaccine in Coimbatore | Coimbatore News – Times of India

COIMBATORE: As many as 2.45 lakh people have skipped their second dose of covid-19 vaccination in Coimbatore city. The health wing of the city corporation has taken out the list … Read More

Covaxin shows 50% effectiveness against symptomatic Covid-19 in real-world assessment: Lancet study | India News – Times of India

NEW DELHI: Two doses of Covaxin are 50 per cent effective against symptomatic Covid-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious … Read More

Break the chain of fake news, try Times Verified | India News – Times of India

* “Are newborn calves being slaughtered in order to produce Covaxin vaccine?”* “Please get your car refuelled. From tomorrow, the pumps have been instructed by police to give fuel only … Read More

Lost 10 years of my life in 18 months, says Dr Krishna Ella | Hyderabad News – Times of India

HYDERABAD: The Covid-19 pandemic brought the world to a standstill. But Bharat Biotech chairman and managing director Dr Krishna Ella was living life in an accelerated mode. He believes he … Read More

Third Covid dose is the real booster, the magic bullet: Dr Krishna M Ella | Hyderabad News – Times of India

HYDERABAD: In a candid conversation, Dr Krishna M Ella, chairman and managing director of Bharat Biotech, tells Swati Bharadwaj and Swati Rathor about vaccines, his passion for science and innovation … Read More

covaxin: Covaxin well tolerated, phase 3 data shows 77.8% efficacy against symptomatic Covid: Lancet | India News – Times of India

HYDERABAD: A week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, a prestigious medical journal Lancet has stated that the phase 3 data of India’s … Read More